Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                CDRH Offices

CDRH Offices
            
                        Office of the Center Director
          Office of Communication and Education
          Office of Management
          Office of Policy
          Office of Product Evaluation and Quality
          Office of Science and Engineering Laboratories
          Office of Strategic Partnerships and Technology Innovation Home
          About FDA
          FDA Organization
          Center for Devices and Radiological Health
          CDRH Offices
          OHT7: Office of In Vitro Diagnostics, Office of Product Evaluation and QualityCDRH Offices OHT7: Office of In Vitro Diagnostics, Office of Product Evaluation and Quality

    
Share
    Post
    Linkedin

    Email
    PrintWho We Are

The Office of Health Technology 7: Office of In Vitro Diagnostics within CDRH's Office of Product Evaluation and Quality (OPEQ) is responsible for the total product lifecycle (TPLC) activities for in vitro diagnostics.

What We Do

For in vitro diagnostics medical devices, we:

Implement a TPLC model for the office's medical device product area.  The TPLC model includes implementation of premarket review programs (e.g., 510(k), PMA, HDE, DeNovo, IDE), compliance and quality programs (e.g., Establishment Inspection Report, Regulatory Audit Reports, Recalls, Allegations of Regulatory Misconduct, Labeling, Enforcement Actions), and surveillance programs (e.g., Medical Device Reports, Post Market Surveillance Studies, Safety Signals).
	Serve as the primary source for scientific and medical expertise with regard to safety and effectiveness of medical devices throughout the total product lifecycle.
	Provide initial support for questions related to regulatory programs in response to requests from medical device and health technology industries, trade associations, other Federal agencies, other countries, State agencies, and the general public.
	Advise, coordinate, and provide consultation to the OPEQ Director and other Agency officials on Office programs and policies concerning premarket review, compliance and quality, and postmarket surveillance activities.
	Participate in the development of national and international consensus standards, and voluntary guidelines through interaction with national and international standards committees.
	Categorize tests based on complexity, make determinations on requests for Waiver by Application, and develops rules and guidance for Clinical Laboratory Improvement Amendments (CLIA) complexity categorization.Office Organization

DCTD: Division of Chemistry and Toxicology Devices

Who We Are

The Division of Chemistry and Toxicology Devices is responsible for review of chemistry and toxicology in vitro diagnostic devices, such as in vitro diagnostics for clinical chemical devices, diabetes, toxicology and cardio-renal.

What We Do

For chemistry and toxicology in vitro diagnostic devices, such as in vitro diagnostics for clinical chemical devices, diabetes, toxicology and cardio-renal medical devices, we:

Coordinate, carry out, and make premarket review determinations (e.g., 510(k), PMA, HDE, DeNovo, IDE, etc.).
	Coordinate, carry out and make postmarket compliance and quality determinations (e.g., Establishment Inspection Report, Regulatory Audit Reports, Recalls, Allegations of Regulatory Misconduct, Labeling, Enforcement Actions, etc.).
	Coordinate, carry out, and make postmarket surveillance determinations (e.g., Medical Device Reports, Post Market Surveillance Studies, Safety Signals, etc.).
	Participate in development and interpretation of regulations and policies.
	Coordinate actions on device and recall classifications.
	Review and evaluate design, test, and production data and reports from manufacturers to ensure compliance with promulgated standards and regulations.

DIHD: Division of Immunology and Hematology Devices

Who We Are

The Division of Immunology and Hematology is responsible for review of immunology and hematology in vitro diagnostics devices.

What We Do

For immunology and hematology in vitro diagnostics devices, we:

Coordinate, carry out, and make premarket review determinations (e.g., 510(k), PMA, HDE, DeNovo, IDE).
	Coordinate, carry out and make postmarket compliance and quality determinations (e.g., Establishment Inspection Report, Regulatory Audit Reports, Recalls, Allegations of Regulatory Misconduct, Labeling, Enforcement Actions).
	Coordinate, carry out, and make postmarket surveillance determinations (e.g., Medical Device Reports, Post Market Surveillance Studies, Safety Signals).
	Participate in development and interpretation of regulations and policies.
	Coordinate actions on device and recall classifications.
	Review and evaluate design, test, and production data and reports from manufacturers to ensure compliance with promulgated standards and regulations.

DMD: Division of Microbiology Devices

Who We Are

The Division of Microbiology Devices is responsible for review of microbial in vitro diagnostics, including viral respiratory, human papilloma virus, general viral, hepatitis, general bacteria, antimicrobial susceptibility, bacterial respiratory and medical countermeasures diagnostic devices.

What We Do

For microbial in vitro diagnostics, including viral respiratory, human papilloma virus, general viral, hepatitis, general bacteria, antimicrobial susceptibility, bacterial respiratory and medical countermeasures diagnostic devices, we:

Coordinate, carry out, and make premarket review determinations (e.g., 510(k), PMA, HDE, DeNovo, IDE).
	Coordinate, carry out and make postmarket compliance and quality determinations (e.g., Establishment Inspection Report, Regulatory Audit Reports, Recalls, Allegations of Regulatory Misconduct, Labeling, Enforcement Actions).
	Coordinate, carry out, and make postmarket surveillance determinations (e.g., Medical Device Reports, Post Market Surveillance Studies, Safety Signals).
	Participate in development and interpretation of regulations and policies.
	Coordinate actions on device and recall classifications.
	Review and evaluate design, test, and production data and reports from manufacturers to ensure compliance with promulgated standards and regulations.

DMGP: Division of Molecular Genetics and Pathology

Who We Are

The Division of Molecular Genetics and Pathology is responsible for review of molecular genetics and pathology in vitro diagnostics, and companion diagnostics.

What We Do

For molecular genetics and pathology in vitro diagnostics, and companion diagnostics medical devices, we:

Coordinate, carry out, and make premarket review determinations (e.g., 510(k), PMA, HDE, DeNovo, IDE).
	Coordinate, carry out and make postmarket compliance and quality determinations (e.g., Establishment Inspection Report, Regulatory Audit Reports, Recalls, Allegations of Regulatory Misconduct, Labeling, Enforcement Actions).
	Coordinate, carry out, and make postmarket surveillance determinations (e.g., Medical Device Reports, Post Market Surveillance Studies, Safety Signals).
	Participate in development and interpretation of regulations and policies.
	Coordinate actions on device and recall classifications.
	Review and evaluate design, test, and production data and reports from manufacturers to ensure compliance with promulgated standards and regulations.

DPOM: Division of Program Operations and Management

Who We Are

The Division of Program Operations and Management is responsible for office specific programs such as the Clinical Laboratory Improvement Amendments (CLIA) program, and office operations.

What We Do

Develop and implement policy and processes to ensure quality and consistency across the regulatory submission programs.
	Determine policy for and oversee the Clinical Laboratory Improvement Amendments (CLIA) program.
	Provide support to industry when interfacing with the various regulatory submission programs managed in DPOM.

Contact Us

For specific phone numbers and email addresses for each office, see the CDRH Management Directory by Organization.

For general questions about medical devices regulation, contact the Division of Industry and Consumer Education at dice@fda.hhs.gov or 800.638.2041 or 301.796.7100.

                                                                                  Content current as of:
      09/21/2022CDRH Offices
            
          
                        Office of the Center Director
          Office of Communication and Education
          Office of Management
          Office of Policy
          Office of Product Evaluation and Quality
          Office of Science and Engineering Laboratories
          Office of Strategic Partnerships and Technology Innovation
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop